OR WAIT null SECS
August 01, 2019
Biopharma industry faces production challenges as gene therapies move from clinical to commercialization.
July 01, 2019
Research from the Institute for Research in Biomedicine offers insight into the source of asymmetry between nucleic acid hybrids.
June 19, 2019
New CDMO facility supports early-stage API manufacturing and scale up.
June 13, 2019
In this collaboration, AbCellera will apply its expertise to generate panels of antibody candidates for Gilead to evaluate.
May 28, 2019
Eli Lilly is set to acquire exclusive worldwide rights for potential non-opioid treatment CNTX-0290 from Centrexion Therapeutics in a deal potentially worth $997.5 million.
May 01, 2019
The companies will join forces to use artificial intelligence (AI) and machine learning to discover and develop new treatments for two chronic diseases.
April 24, 2019
University of Southern California scientists have made an advancement in chimeric antigen receptor (CAR) T-cell therapy that seems to eliminate its severe side effects, making the treatment safer and potentially available in outpatient settings.
April 09, 2019
Catalent invests $5 million in hot melt extrusion capabilities at Somerset, NJ facility.
March 27, 2019
Worth up to $605 million, the collaboration will focus on studying a preclinical novel target that could lead to potential new treatments for autoimmune diseases.
March 20, 2019
Think ahead to production requirements when planning strategies in early development of gene and cell therapies.